|
Market Closed -
Bombay S.E.
06:03:03 2026-09-11 EDT
|
5-day change | 1st Jan Change | ||
| 4,975.00 INR | +0.95% |
|
+2.58% | +29.50% |
| 09-08 | India's Torrent Gas files updated IPO papers | RE |
| 07-30 | Torrent Pharmaceuticals Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
| Market Cap | 1,892B 19.81B 17.07B 16.16B 14.65B 27.48B 27.62B 192B 73.8B 963B 74.39B 72.76B 3,042B | P/E 2027 * |
73.9x | P/E 2028 * | 53.5x |
|---|---|---|---|---|---|
| Enterprise Value | 2,014B 21.08B 18.17B 17.2B 15.59B 29.25B 29.4B 204B 78.56B 1,025B 79.19B 77.45B 3,238B | EV / Sales 2027 * |
10.2x | EV / Sales 2028 * | 8.91x |
| Free-Float |
36.58% | Yield 2027 * |
0.66% | Yield 2028 * | 0.77% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| TORNTPHARM | Delayed | |
NSE India S.E.
| TORNTPHARM | Delayed |
Last Transcript : Torrent Pharmaceuticals Limited
| 1 day | +0.95% | ||
| 1 week | +2.58% | ||
| Current month | -0.06% | ||
| 1 month | +2.02% | ||
| 3 months | +8.74% | ||
| 6 months | +13.38% | ||
| Current year | +29.50% |
| 1 week | 4,885.9 |  | 4,999 |
| 1 month | 4,762.1 | | 5,049 |
| Current year | 3,724.1 | | 5,249.95 |
| 1 year | 3,480 | | 5,249.95 |
| 3 years | 1,822.25 | | 5,249.95 |
| 5 years | 1,242.5 | | 5,249.95 |
| 10 years | 571.75 | | 5,249.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aman Samir Mehta
CEO | Chief Executive Officer | 34 | 2025-07-31 |
Sudhir Menon
DFI | Director of Finance/CFO | - | 2018-08-31 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 62 | 2014-07-29 | |
Nayantara Bali
BRD | Director/Board Member | 59 | 2019-03-06 |
| Director/Board Member | 59 | 2022-07-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/29/24 | Buy | Chief Operating Officer | 930,144 | 0.2748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.95% | +2.58% | +39.50% | +166.28% | 19.81B | |
| -0.65% | -2.93% | +47.70% | +86.30% | 994B | |
| -0.29% | -3.51% | +49.15% | +61.95% | 640B | |
| +0.83% | +0.26% | +17.76% | +70.10% | 454B | |
| -0.38% | -3.59% | +30.13% | +34.14% | 337B | |
| -0.09% | -13.54% | +13.34% | +24.74% | 261B | |
| -0.43% | -2.48% | -0.73% | +10.64% | 246B | |
| -1.34% | -13.70% | +36.53% | +46.70% | 204B | |
| -3.44% | -7.51% | -20.63% | -58.97% | 190B | |
| -0.75% | -4.82% | +25.46% | +85.90% | 178B | |
| Average | -0.56% | -4.92% | +23.82% | +52.78% | 352.46B | |
| Weighted average by Cap. | -0.50% | -4.38% | +31.01% | +55.28% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 198B 2.07B 1.79B 1.69B 1.53B 2.88B 2.89B 20.09B 7.72B 101B 7.79B 7.62B 318B | 223B 2.33B 2.01B 1.9B 1.72B 3.24B 3.25B 22.6B 8.69B 113B 8.76B 8.57B 358B |
| Net income | 24.72B 259M 223M 211M 191M 359M 361M 2.51B 964M 12.58B 972M 951M 39.74B | 34.25B 359M 309M 293M 265M 497M 500M 3.47B 1.34B 17.43B 1.35B 1.32B 55.07B |
| Net Debt | 122B 1.28B 1.1B 1.04B 944M 1.77B 1.78B 12.37B 4.76B 62.07B 4.8B 4.69B 196B | 93.6B 980M 844M 799M 724M 1.36B 1.37B 9.49B 3.65B 47.62B 3.68B 3.6B 150B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-11 | ₹4,975.00 | +0.95% | 2,424 |
| 26-09-10 | ₹4,928.40 | -0.07% | 18,703 |
| 26-09-09 | ₹4,931.90 | -0.62% | 6,717 |
| 26-09-08 | ₹4,962.75 | +1.01% | 4,158 |
| 26-09-07 | ₹4,913.00 | +1.30% | 16,490 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TORNTPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
